General
Preferred name
Telacebec
Synonyms
IAP6 ()
Q203 ()
Q-203 ()
Q203 from Novartis/NITD ()
Telacebec (Q203) ()
P&D ID
PD061445
CAS
1334719-95-7
Tags
available
drug candidate
Drug Status
investigational
Max Phase
Phase 2
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Compound Sets
12
AdooQ Bioactive Compound Library
A12310
Cayman Chemical Bioactives
37323
ChEMBL Drugs
CHEMBL3298910
Drug Repurposing Hub
DrugBank
DB17754
Enamine BioReference Compounds
MedChem Express Bioactive Compound Library
HY-101040
Pandemic Response Box
ReFrame library
Selleckchem Bioactive Compound Library
telacebec-q203
TargetMol Bioactive Compound Library
T5400
The Pathogen Box
External IDs
17
Properties
(calculated by RDKit )
Molecular Weight
556.19
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
1
Rotatable Bonds
7
Ring Count
5
Aromatic Ring Count
4
cLogP
6.76
TPSA
58.87
Fraction CSP3
0.31
Chiral centers
0.0
Largest ring
6.0
QED
0.27
Structural alerts
1
anil_di_alk_D(198)
c:1:c:c(:c:c:c:1-[#7](-[#6;X4])-[#6;X4])-[#6;X4]-[$([#8]-[#1]),$([#6]=[#6]-[#1]),$([#7]-[#6;X4])]
PAINS Family A
Custom attributes
(extracted from source data)
Disease
TUBERCULOSIS
Pathway
Microbiology&virology
Anti-infection
Target
tuberculosis
antibiotic
Bacterial
MOA
Antibiotic
ATP synthase inhibitor
Source data